Purchase Order 36C24423P0327
Award Date
6/29/23
Potential Completion Date
6/28/24
Potential Value
$417K
Federal Agency
Veterans Integrated Service Network 4
Awardee
Cardinal Health 414, LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lebanon, PA 17042, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 4 (VISN 4) of the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the supply of the radiopharmaceutical Xofigo (radium-223 dichloride) for prostate cancer treatment. The contract has a ceiling value of $170,415.00 and a period of performance through June 28, 2026. Cardinal Health 414, LLC is a major supplier of...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 17 to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the supply of Xofigo (radium-223 dichloride), a radiopharmaceutical therapy for prostate cancer treatment. The contract has a ceiling value of $110,610.65 and a period of performance ending on February 28, 2025. Cardinal Health 414, LLC is a prominent supplier of...
This firm fixed-price purchase order contract was awarded by the Veterans Integrated Service Network 4 (VISN 4), a division of the U.S. Department of Veterans Affairs (VA), to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract has a ceiling value of $64,325.92 and is for the delivery of the radiopharmaceutical Xofigo (radium-223 dichloride) to support nuclear medicine and oncology services for the VA healthcare system. The contract has an ultimate completion date of...
This is a firm-fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of the radiopharmaceutical Xofigo, used in the treatment of prostate cancer. The contract has a potential value of $12,970.58 and a completion date of February 10, 2023. Cardinal Health 414 is a major supplier of radiopharmaceuticals, radioactive isotopes, and other...
This is a $12,623.78 firm fixed-price purchase order awarded by the Veterans Integrated Service Network 8 (VISN 8), a component of the U.S. Department of Veterans Affairs (VA), to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the supply of the radiopharmaceutical product XOFIGO, used in the treatment of prostate cancer. Cardinal Health 414 is a key provider of radiopharmaceuticals, radioactive isotopes, and specialty pharmaceuticals to federal healthcare...
This is a $32,295.44 firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC for the delivery of XOFIGO RA 223, a radiopharmaceutical product, with a completion date of February 29, 2024. Cardinal Health 414, LLC is a subsidiary of the global healthcare company Cardinal Health, Inc. and has previously received numerous indefinite delivery contracts from the VA and other federal health agencies to provide a...
This is a $31,018.03 firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC for the emergency supply of the radiopharmaceutical Xofigo (radium-223 dichloride) for prostate cancer treatment. Cardinal Health 414 is a subsidiary of the global healthcare services company Cardinal Health, Inc. and specializes in providing radiopharmaceuticals and related products to federal agencies, including the VA, Department of Defense, and National...
This is a firm-fixed-price purchase order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Cardinal Health, Inc. for the delivery of the radiopharmaceutical product RA 223 XOFIGO. The contract has a potential value of $127,271.03 and a period of performance from October 1, 2020 to May 31, 2022. Cardinal Health, a global healthcare services and products company, will leverage its distribution infrastructure and nuclear pharmacy expertise to supply this...
This federal contract award, valued at $12,623.78, was issued by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of Xofigo (radium-223 dichloride), a radiopharmaceutical therapy used to treat prostate cancer. Cardinal Health 414 is a major supplier of radiopharmaceuticals, radioactive isotopes, and related products to federal healthcare agencies including the VA, Department of Defense, and National...
This federal contract award, valued at $261,303.00, was issued by the Veterans Integrated Service Network 4 (VISN 4) of the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC for the supply of the radiopharmaceutical product Xofigo (radium-223 dichloride). The contract is a firm fixed-price purchase order with an ultimate completion date of April 11, 2026. Cardinal Health 414, LLC is a subsidiary of the larger Cardinal Health, Inc., a global healthcare services company that...